Response to Zoledronic Acid Infusion in Children With Fibrous Dysplasia

Objective: This retrospective study evaluated the outcome and safety of long-term treatment with zoledronic acid, in both polyostotic and mono-ostotic fibrous dysplasia (FD) of children. Methods: The case records of children and adolescents with symptomatic FD who received zoledronic acid (0.1 mg/kg...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathy, Sujit Kumar, Swaroop, Shakti, Velagada, Sandeep, Priyadarshini, Debashree, Das, Rashmi Ranjan, Satpathy, Amit Kumar, Agrawal, Kanhaiyalal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732464/
https://www.ncbi.nlm.nih.gov/pubmed/33330278
http://dx.doi.org/10.3389/fped.2020.582316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732464/
https://www.ncbi.nlm.nih.gov/pubmed/33330278
http://dx.doi.org/10.3389/fped.2020.582316

Ejemplares similares